×
It looks like you're using an obsolete version of internet explorer. Internet explorer is no longer supported by Microsoft since the end of 2015. We invite you to use a newer browser such as Firefox, Google Chrome or Microsoft Edge.

Become an Oncostream member and receive full access to its content!

You must be an Oncostream member to access videos without any restrictions. Register for free in one minute and access all services provided by Oncostream.You will also be able to log into Oncostream from your Facebook or twitter account by clicking on login on the top-right corner of Oncostream website.

Registration Login


Worldwide schedules comment Share

Modérateurs :
Guillaume Bataillon
Benoit You

 

Intervenants :
Stéphanie Nougaret
Guillaume Bataillon
Benoit You
Gwenaël Ferron

 

Agenda

18:00 Vision du radiologue de la carcinose
Stéphanie Nougaret
 
18:20 Vision de l'Anapath pour le CRS et IA
Guillaume Bataillon
 
18:40 Vision de l'oncologue
Benoit You
 
19:00 Vision du chirurgien pour le PCI, See2cure
Gwenaël Ferron
 
19:20 Débat/Discussion – Réponses aux questions
 

 

Shooting date : 2025-04-15
Last update : 2025-05-19
1 comment
Join the Discussion
  • Marianne P. marianne persyn
    14510012100

      Please, select your files, click upload button, write your comment and click the send button. (allowed formats : images jpeg, gif, png, and PDF)
      Your browser doesn't have Flash, Silverlight or HTML5 support.


    Suggestions

    Wednesday, March 26th 2025 from 01pm to 01:45pm (GMT+1)
    Honolulu : Wednesday, March 26th 2025 from 01am to 01:45am (GMT+1)
    San Francisco : Wednesday, March 26th 2025 from 03am to 03:45am (GMT+1)
    New York : Wednesday, March 26th 2025 from 06am to 06:45am (GMT+1)
    Buenos Aires : Wednesday, March 26th 2025 from 08am to 08:45am (GMT+1)
    London / Dublin : Wednesday, March 26th 2025 from 11am to 11:45am (GMT+1)
    Paris / Berlin : Wednesday, March 26th 2025 from 12pm to 12:45pm (GMT+1)
    Istanbul : Wednesday, March 26th 2025 from 01pm to 01:45pm (GMT+1)
    Moscou / Dubaï : Wednesday, March 26th 2025 from 03pm to 03:45pm (GMT+1)
    Bangkok : Wednesday, March 26th 2025 from 06pm to 06:45pm (GMT+1)
    Shanghai : Wednesday, March 26th 2025 from 07pm to 07:45pm (GMT+1)
    Tokyo : Wednesday, March 26th 2025 from 08pm to 08:45pm (GMT+1)
    Sydney : Wednesday, March 26th 2025 from 09pm to 09:45pm (GMT+1)
    Wellington : Wednesday, March 26th 2025 from 11pm to 11:45pm (GMT+1)

    Comment prendre en charge un cancer de l'endomètre avancé ?

    Cancer de l’endomètre avancé en rechute précoce : que proposer en 2025 ? (épisode 2)

    Share
    Tuesday, December 13th 2022 from 06pm to 07:30pm (GMT+1)
    Honolulu : Tuesday, December 13th 2022 from 06am to 07:30am (GMT+1)
    San Francisco : Tuesday, December 13th 2022 from 08am to 09:30am (GMT+1)
    New York : Tuesday, December 13th 2022 from 11am to 12:30pm (GMT+1)
    Buenos Aires : Tuesday, December 13th 2022 from 01pm to 02:30pm (GMT+1)
    London / Dublin : Tuesday, December 13th 2022 from 04pm to 05:30pm (GMT+1)
    Paris / Berlin : Tuesday, December 13th 2022 from 05pm to 06:30pm (GMT+1)
    Istanbul : Tuesday, December 13th 2022 from 06pm to 07:30pm (GMT+1)
    Moscou / Dubaï : Tuesday, December 13th 2022 from 08pm to 09:30pm (GMT+1)
    Bangkok : Tuesday, December 13th 2022 from 11pm to 12:30am (GMT+1)
    Shanghai : Wednesday, December 14th 2022 from 12am to 01:30am (GMT+1)
    Tokyo : Wednesday, December 14th 2022 from 01am to 02:30am (GMT+1)
    Sydney : Wednesday, December 14th 2022 from 02am to 03:30am (GMT+1)
    Wellington : Wednesday, December 14th 2022 from 04am to 05:30am (GMT+1)

    Last improvements in advanced ovarian cancer treatment

    Trials that have or will impact practices in the management of patients with advanced ovarian cancer

    Share
    Tuesday, September 5th 2023 from 06:30pm to 08pm (GMT+2)
    Honolulu : Tuesday, September 5th 2023 from 06:30am to 08am (GMT+2)
    San Francisco : Tuesday, September 5th 2023 from 09:30am to 11am (GMT+2)
    New York : Tuesday, September 5th 2023 from 12:30pm to 02pm (GMT+2)
    Buenos Aires : Tuesday, September 5th 2023 from 01:30pm to 03pm (GMT+2)
    Reykjavik : Tuesday, September 5th 2023 from 04:30pm to 06pm (GMT+2)
    London / Dublin : Tuesday, September 5th 2023 from 05:30pm to 07pm (GMT+2)
    Paris / Berlin : Tuesday, September 5th 2023 from 06:30pm to 08pm (GMT+2)
    Istanbul : Tuesday, September 5th 2023 from 07:30pm to 09pm (GMT+2)
    Moscou / Dubaï : Tuesday, September 5th 2023 from 08:30pm to 10pm (GMT+2)
    Bangkok : Tuesday, September 5th 2023 from 11:30pm to 01am (GMT+2)
    Shanghai : Wednesday, September 6th 2023 from 12:30am to 02am (GMT+2)
    Tokyo : Wednesday, September 6th 2023 from 01:30am to 03am (GMT+2)
    Sydney : Wednesday, September 6th 2023 from 03:30am to 05am (GMT+2)
    Wellington : Wednesday, September 6th 2023 from 05:30am to 07am (GMT+2)

    Les nouveaux enjeux de la prise en charge du cancer de l’ovaire en première ligne : L’exemple d...

    Cycle d'enseignement sur le cancer de l'ovaire - Première session

    Share
    Wednesday, March 20th 2024 from 07pm to 08pm (GMT+1)
    Honolulu : Wednesday, March 20th 2024 from 07am to 08am (GMT+1)
    San Francisco : Wednesday, March 20th 2024 from 09am to 10am (GMT+1)
    New York : Wednesday, March 20th 2024 from 12pm to 01pm (GMT+1)
    Buenos Aires : Wednesday, March 20th 2024 from 02pm to 03pm (GMT+1)
    London / Dublin : Wednesday, March 20th 2024 from 05pm to 06pm (GMT+1)
    Paris / Berlin : Wednesday, March 20th 2024 from 06pm to 07pm (GMT+1)
    Istanbul : Wednesday, March 20th 2024 from 07pm to 08pm (GMT+1)
    Moscou / Dubaï : Wednesday, March 20th 2024 from 09pm to 10pm (GMT+1)
    Bangkok : Thursday, March 21st 2024 from 12am to 01am (GMT+1)
    Shanghai : Thursday, March 21st 2024 from 01am to 02am (GMT+1)
    Tokyo : Thursday, March 21st 2024 from 02am to 03am (GMT+1)
    Sydney : Thursday, March 21st 2024 from 03am to 04am (GMT+1)
    Wellington : Thursday, March 21st 2024 from 05am to 06am (GMT+1)

    Immunothérapies et inhibiteurs de PARP dans la prise en charge du cancer de l’endomètre avancé ...

    éclairages du congrès de la SGO

    Share
    Scroll Up